InvestorsHub Logo
Followers 5
Posts 323
Boards Moderated 0
Alias Born 07/27/2010

Re: jbog post# 14787

Sunday, 11/01/2015 5:48:24 PM

Sunday, November 01, 2015 5:48:24 PM

Post# of 20689
I believe that some insurers/plans will no longer cover thrice weekly Copaxone or the 20 mg Copaxone and begin to financially direct those users to Glatopa.

Two groups that I work with appear to be planning this and one of these never went to thrice weekly Copaxone as a formulary drug, recognizing a generic 20 mg formulation had a decent chance of approval.